Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela A Bota

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|September 2, 2014
Therapeutic targeting of malignant gliomaDaniela Alexandru-Abrams, Martin R Jadus, Frank P Hsu, et al.
CNS Oncology|March 18, 2017
Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcomaPejman Majd, Daniel E O'Connell, Ronald C Kim, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomasDaniela A Bota, Annick Desjardins, Jennifer A Quinn, et al.
Pediatric Blood & Cancer|June 11, 2021
Exploring the role and clinical implications of proteasome inhibition in medulloblastomaClay M Hoerig, Ashley S Plant-Fox, Michelle D Pulley, et al.
The Permanente Journal|December 24, 2013
Antivascular endothelial growth factor antibody for treatment of glioblastoma multiformeJoseph A Hanson, Frank P K Hsu, Arun T Jacob, et al.
AJR. American Journal of Roentgenology|October 6, 2017
Imaging Genetic Heterogeneity in Glioblastoma and Other Glial Tumors: Review of Current Methods and Future DirectionsDaniel Chow, Peter Chang, Brent D Weinberg, et al.
Journal of Neuro-Oncology|March 2, 2011
Primary leptomeningeal plasmablastic lymphomaMarlon S Mathews, Daniela A Bota, Ronald C Kim, et al.
Journal of Neurosurgery|October 8, 2013
Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesisDaniela A Bota, Daniela Alexandru, Stephen T Keir, et al.
Experimental Neurology|February 9, 2024
Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicityNaomi Lomeli, Diana C Pearre, Maureen Cruz, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2023
Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastomaBhaskar C Das, Javier J Lepe, Mohammed Adil Shareef, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Anti-Cancer Agents in Medicinal Chemistry|September 2, 2014
Therapeutic targeting of malignant gliomaDaniela Alexandru-Abrams, Martin R Jadus, Frank P Hsu, et al.
CNS Oncology|March 18, 2017
Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcomaPejman Majd, Daniel E O'Connell, Ronald C Kim, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomasDaniela A Bota, Annick Desjardins, Jennifer A Quinn, et al.
Pediatric Blood & Cancer|June 11, 2021
Exploring the role and clinical implications of proteasome inhibition in medulloblastomaClay M Hoerig, Ashley S Plant-Fox, Michelle D Pulley, et al.
The Permanente Journal|December 24, 2013
Antivascular endothelial growth factor antibody for treatment of glioblastoma multiformeJoseph A Hanson, Frank P K Hsu, Arun T Jacob, et al.
AJR. American Journal of Roentgenology|October 6, 2017
Imaging Genetic Heterogeneity in Glioblastoma and Other Glial Tumors: Review of Current Methods and Future DirectionsDaniel Chow, Peter Chang, Brent D Weinberg, et al.
Journal of Neuro-Oncology|March 2, 2011
Primary leptomeningeal plasmablastic lymphomaMarlon S Mathews, Daniela A Bota, Ronald C Kim, et al.
Journal of Neurosurgery|October 8, 2013
Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesisDaniela A Bota, Daniela Alexandru, Stephen T Keir, et al.
Experimental Neurology|February 9, 2024
Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicityNaomi Lomeli, Diana C Pearre, Maureen Cruz, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2023
Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastomaBhaskar C Das, Javier J Lepe, Mohammed Adil Shareef, et al.
Pageof 9